Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The effects of setarud on the immunological status of HIV-positive patients: Efficacy of a novel multi-herbal drug

Autor: Baeis, Mehdi Gholamzadeh, Amiri, Ghasem, mojtaba miladinia

Publikováno v: Avicenna Journal of Phytomedicine, Vol 7, Iss 3, Pp 232-241 (2017)
ResearcherID
Avicenna Journal of Phytomedicine

Objective: This study examines the effect of the addition of IMOD, a novel multi-herbal drug to the highly active anti-retroviral therapy (HAART) regimen, on the immunological status of HIV-positive patients. Materials and Methods: A randomized two-p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::457b5aa47ed6eb7f68e42c90e4e76b6f
http://ajp.mums.ac.ir/article_8169_54caab9355d49bc7a705197acc62b1e5.pdf

Computer-aided design of novel HIV-1 entry inhibitors blocking the virus envelope gp120 V3 loop

Autor: M. A. Kisel, Alexander M. Andrianov, Igor I. Kucherov, A. V. Tuzikov, V. F. Eremin, Ivan Anishchenko, V. A. Nikolayevich, Yu. V. Kornoushenko

Publikováno v: Biopolymers and Cell, Vol 28, Iss 6, Pp 468-476 (2012)

Aim. The object of this study was to implement computer-aided design of the water-soluble analog of glycolipid β -galactosylceramide (β-GalCer), which presents a potential HIV-1 entry inhibitor, by the analysis of intermolecular interactions of β-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a403ad25b6b86086b157d9c4c0b60d2e
http://biopolymers.org.ua/pdf/en/28/6/468/

Studies in computational biology of HIV-1

Autor: Mohammadi, Pejman

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e9fcee4ae6659e02eba808d536b6eea

Patents, Innovation and Public Health: Brazilian Public-Sector Laboratories' Experience in Copying AIDS Drugs

Autor: Cassier, Maurice, Correa, Marilena

Publikováno v: Economics of AIDS and Access to HIV/AIDS Care in Developing Countries. Issues and Challenge
Economics of AIDS and Access to HIV/AIDS Care in Developing Countries. Issues and Challenge, 2003

International audience; The Brazilian experience in producing HIV/AIDS drugs is based on the lawful copying of medicines patented abroad, on a health policy of universal access to antiretrovirals (ARV), and on technological learning, especially in pu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2d060c3e83af31b0183331ab59604ba3
https://halshs.archives-ouvertes.fr/halshs-02162784/file/Cassier.pdf